Vitreomacular adhesion and neovascular age-related macular degeneration.
We explore the hypothesis that vitreomacular adhesion (VMA) and vitreomacular traction (VMT) play a role in the pathogenesis and clinical course of neovascular ("wet") age-related macular degeneration (AMD). Several biological theories are offered to explain this possible association, including direct tractional force, altered vitreous oxygenation, altered diffusion coefficients of intravitreal molecules, and alterations in the pharmacokinetics of intravitreal drugs. Release of VMT may improve the clinical course of neovascular AMD, and a few case series suggest that vitrectomy can lead to both a functional and anatomic improvement. A large, randomized, controlled clinical trial is underway, investigating pharmacologic release of VMA in eyes with neovascular AMD.
King's College London and King's College Hospital, London, United Kingdom.
Andrew R H
AR
Simpson
Robert
R
Petrarca
Timothy L
TL
Jackson
D005128:Eye Diseases / Q000150:complications* / Q000175:diagnosis / Q000601:surgery; D006801:Humans; D013508:Ophthalmologic Surgical Procedures; D012164:Retinal Diseases / Q000150:complications* / Q000175:diagnosis / Q000601:surgery; D000267:Tissue Adhesions; D041623:Tomography, Optical Coherence; D014822:Vitreous Body / Q000473:pathology*; D057135:Wet Macular Degeneration / Q000175:diagnosis / Q000209:etiology* / Q000601:surgery